UMUlrike Beate Mayr

Ulrike Beate Mayr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ulrike Beate Mayr has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Alena Atrasheuskaya

    Faculty of Life Science, University of Vienna, Department of Medical/Pharmaceutical Chemistry, Althanstraße 14, UZAII, 2B522, 1090 Vienna, Austria,1 Bird-C GmbH, Schönborngasse 12/12, 1080 Vienna, Austria,2 Institute of Molecular Biology, State Research Centre of Virology and Biotechnology “Vector,” 630559 Novosibirsk Region, Koltsovo, Russia3

    1 shared publication
  • Christoph Haller

    Faculty of Life Science, University of Vienna, Department of Medical/Pharmaceutical Chemistry, Althanstraße 14, UZAII, 2B522, 1090 Vienna, Austria,1 Bird-C GmbH, Schönborngasse 12/12, 1080 Vienna, Austria,2 Institute of Molecular Biology, State Research Centre of Virology and Biotechnology “Vector,” 630559 Novosibirsk Region, Koltsovo, Russia3

    1 shared publication
  • Eugenij Bukin

    Faculty of Life Science, University of Vienna, Department of Medical/Pharmaceutical Chemistry, Althanstraße 14, UZAII, 2B522, 1090 Vienna, Austria,1 Bird-C GmbH, Schönborngasse 12/12, 1080 Vienna, Austria,2 Institute of Molecular Biology, State Research Centre of Virology and Biotechnology “Vector,” 630559 Novosibirsk Region, Koltsovo, Russia3

    1 shared publication
  • Georgy Ignatyev

    Faculty of Life Science, University of Vienna, Department of Medical/Pharmaceutical Chemistry, Althanstraße 14, UZAII, 2B522, 1090 Vienna, Austria,1 Bird-C GmbH, Schönborngasse 12/12, 1080 Vienna, Austria,2 Institute of Molecular Biology, State Research Centre of Virology and Biotechnology “Vector,” 630559 Novosibirsk Region, Koltsovo, Russia3

    1 shared publication
  • Werner Lubitz

    Faculty of Life Science, University of Vienna, Department of Medical/Pharmaceutical Chemistry, Althanstraße 14, UZAII, 2B522, 1090 Vienna, Austria,1 Bird-C GmbH, Schönborngasse 12/12, 1080 Vienna, Austria,2 Institute of Molecular Biology, State Research Centre of Virology and Biotechnology “Vector,” 630559 Novosibirsk Region, Koltsovo, Russia3

    1 shared publication
  • Wolfgang Haidinger

    Faculty of Life Science, University of Vienna, Department of Medical/Pharmaceutical Chemistry, Althanstraße 14, UZAII, 2B522, 1090 Vienna, Austria,1 Bird-C GmbH, Schönborngasse 12/12, 1080 Vienna, Austria,2 Institute of Molecular Biology, State Research Centre of Virology and Biotechnology “Vector,” 630559 Novosibirsk Region, Koltsovo, Russia3

    1 shared publication

Latest Publications

  • Open Access

    Bacterial Ghosts as an Oral Vaccine: a Single Dose of Escherichia coli O157:H7 Bacterial Ghosts Protects Mice against Lethal Challenge

    by Ulrike Beate Mayr, Christoph Haller, Wolfgang Haidinger, Alena Atrasheuskaya, Eugenij Bukin, Werner Lubitz, Georgy Ignatyev

    Enterohemorrhagic Escherichia coli (EHEC) is a bacterial pathogen that is associated with several life-threatening diseases for humans. The combination of protein E-mediated cell lysis to produce EHEC ghosts and staphylococcal nuclease A to degrade DNA was used for the development of an oral EHEC vaccine. The lack of genetic material in the oral EHEC bacterial-ghost vaccine abolished any hazard of horizontal gene transfer of resistance genes or pathogenic islands to resident gut flora. Intragastric immunization of mice with EHEC ghosts without the addition of any adjuvant induced cellular and humoral immunity. Immunized mice challenged at day 55 showed 86% protection against lethal challenge with a heterologous EHEC strain after single-dose oral immunization and 93.3% protection after one booster at day 28, whereas the controls showed 26.7% and 30% survival, respectively. These results indicate that it is possible to develop an efficacious single-dose oral EHEC bacterial-ghost vaccine.